Related references
Note: Only part of the references are listed.Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas
Alexander Pemov et al.
NEURO-ONCOLOGY (2019)
NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY
Brian Weiss et al.
NEURO-ONCOLOGY (2018)
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors
Christine S. Higham et al.
NEURO-ONCOLOGY (2018)
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview
Markku M. Miettinen et al.
HUMAN PATHOLOGY (2017)
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Elina Uusitalo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Rosa Nguyen et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Optimizing biologically targeted clinical trials for neurofibromatosis
David H. Gutmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Recommendations for imaging tumor response in neurofibromatosis clinical trials
Eva Dombi et al.
NEUROLOGY (2013)
18-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Evaluation of Nodular Lesions in Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas (PN) or Malignant Peripheral Nerve Sheath Tumors (MPNST)
Holly Meany et al.
PEDIATRIC BLOOD & CANCER (2013)
Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
Carlos E. Prada et al.
JOURNAL OF PEDIATRICS (2012)
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1
Rosa Nguyen et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Atypical Neurofibromas in Neurofibromatosis Type 1 are Premalignant Tumors
Eline Beert et al.
GENES CHROMOSOMES & CANCER (2011)
Resection of Plexiform Neurofibromas in Children With Neurofibromatosis Type 1
Federico Canavese et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2011)
Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Frequency and Associated Clinical Deficits
Rosa Nguyen et al.
JOURNAL OF PEDIATRICS (2011)
Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas
A. Kim et al.
NEUROLOGY (2009)
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
T. Tucker et al.
JOURNAL OF MEDICAL GENETICS (2009)
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Victor-F. Mautner et al.
NEURO-ONCOLOGY (2008)
NF1 plexiform neurofibroma growth rate by volumetric MRI - Relationship to age and body weight
E. Dombi et al.
NEUROLOGY (2007)
Association between benign and malignant peripheral nerve sheath tumors in NF1
T Tucker et al.
NEUROLOGY (2005)
Superficial neurofibroma: A lesion with unique MRI characteristics in patients with neurofibromatosis type 1
R Lim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging
J Solomon et al.
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS (2004)
Share Paper
